News for Edesa Biotech, Inc. (EDSA)

Lucid Capital has initiated coverage on Edesa Biotech (EDSA) with a Buy rating, setting a price target of $9. The firm expresses optimism regarding Edesa's lead

TORONTO, April 28, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therape

**media[608088]**

Stephen Lemieux appointed as President of NeuPath Health Inc. (TSXV:NPTH), effective May 1, 2025. Lemieux brings over 20 years of experience in healthca

TORONTO, April 04, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therape

**media[586399]**

Overview of the Recent Transaction Stonepine Capital Management, LLC (Trades, Portfolio), a prominent investment firm, recently made a strategic move by acquiri

Ohio-based Energy Focus, Inc. (EFOI) is up over 63 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

TORONTO, Feb. 14, 2025 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company focused on developing host-directed therapeu

**media[541139]**

U.S. stocks traded higher toward the end of trading, with the Dow Jones index surging more than 100 points on Thursday. The Dow traded up 0.33% to 44,514.10 wh...

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 150 points on Thursday. The Dow traded up 0.33% to 44,513.97 while t...

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 0.2% on Thursday. Following the market opening Thursday, the Dow traded...

Canada-based Edesa Biotech, Inc. (EDSA), a clinical-stage biopharmaceutical company is up over 74 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Financing led by Velan Capital with participation from new and existing healthcare-focused institutional investors and insidersCapital raise to fund Edesa's CXC

Pennsylvania-based Lipella Pharmaceuticals Inc. (LIPO), a clinical-stage biotechnology company is up over 180 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

**media[491823]**

Edesa Biotech Reports Fiscal Year 2024 Results

California-based Bolt Projects Holdings, Inc. (BSLK) is up over 233 percent in Friday's pre-market trading. The following are some of the other stocks making big moves in Friday's pre-market trading.